TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Euroform MediPharm AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
21,426
|
23,924
|
25,892 |
Financial expenses |
1
|
80
|
292 |
Earnings before taxes |
326
|
-2,359
|
-8,684 |
EBITDA |
733
|
-1,719
|
-3,353 |
Total assets |
16,216
|
16,547
|
20,061 |
Current assets |
14,366
|
14,356
|
17,041 |
Current liabilities |
6,368
|
6,281
|
8,568 |
Equity capital |
9,737
|
10,028
|
11,153 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
13
![]() |
13
|
12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.0%
|
60.6%
|
55.6% |
Turnover per employee |
1,648
|
1,840
|
2,158 |
Profit as a percentage of turnover |
1.5%
|
-9.9%
|
-33.5% |
Return on assets (ROA) |
2.0%
|
-13.8%
|
-41.8% |
Current ratio |
225.6%
|
228.6%
|
198.9% |
Return on equity (ROE) |
3.3%
|
-23.5%
|
-77.9% |
Change turnover |
-2,622
|
130
|
4,754 |
Change turnover % |
-11%
|
1%
|
22% |
Chg. No. of employees |
0
|
1
|
0 |
Chg. No. of employees % |
0%
|
8%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.